COMP-Angiopoietin-1 promotes cavernous angiogenesis in a type 2 diabetic rat model

Journal of Korean Medical Science

Volumn 28, Issue 5, 2013, Pages 725-730

  Kim, Sun Ouck ^a   Lee, Hyun Suk ^a   Ahn, Kyuyoun ^a   Park, Kwangsung ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Angiogenesis; Angiopoietin 1; Erectile dysfunction; Inbred OLETF; Rats

Indexed keywords

ANGIOPOIETIN 1; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CD31 ANTIGEN; HYBRID PROTEIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; DRUG EFFECT; ERECTILE DYSFUNCTION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LONG EVANS RAT; MALE; METABOLISM; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PATHOLOGY; PENIS; RAT; WESTERN BLOTTING;

ANGIOGENESIS; ANGIOPOIETIN-1; ERECTILE DYSFUNCTION; RATS, INBRED OLETF;

ANGIOPOIETIN-1; ANIMALS; ANTIGENS, CD31; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; CARTILAGE OLIGOMERIC MATRIX PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PENIS; RATS; RATS, LONG-EVANS; RECOMBINANT FUSION PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84878578780     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.5.725     Document Type: Article

References (25)

1. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 yr of age: results from the health professionals follow-up study. Ann Intern Med 2003; 139: 161-8.
2. Heaton JP, Adams MA. Causes of erectile dysfunction. Endocrine 2004; 23: 119-23.
3. Jin HR, Kim WJ, Song JS, Piao S, Tumurbaatar M, Shin SH, Choi MJ, Tuvshintur B, Song KM, Kwon MH, et al. Intracavernous delivery of synthetic angiopoietin-1 protein as a novel therapeutic strategy for erectile dysfunction in the type II diabetic db/db mouse. J Sex Med 2010; 7: 3635- 46.
4. Xie D, Odronic SI, Wu F, Pippen A, Donatucci CF, Annex BH. Mouse model of erectile dysfunction due to diet-induced diabetes mellitus. Urology 2007; 70: 196-201.
5. Luttrell IP, Swee M, Starcher B, Parks WC, Chitaley K. Erectile dysfunction in the type II diabetic db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix. Am J Physiol Heart Circ Physiol 2008; 294: H2204-11.
6. Jesmin S, Sakuma I, Salah-Eldin A, Nonomura K, Hattori Y, Kitabatake A. Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction in diabetes. J Mol Endocrinol 2003; 31: 401-18.
7. Shirai M, Yamanaka M, Shiina H, Igawa M, Kawakami T, Ishii N, Lue TF, Fujime M, Dahiya R. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat. Biochem Biophys Res Commun 2006; 341: 755-62.
8. Dall'Era JE, Meacham RB, Mills JN, Koul S, Carlsen SN, Myers JB, Koul HK. Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model. Int J Impot Res 2008; 20: 307-14.
9. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, Mc- Donald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511-4.
10. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, et al. Isolation of angiopoietin- 1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-9.
11. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-80.
12. Cho CH, Kim KE, Byun J, Jang HS, Kim DK, Baluk P, Baffert F, Lee GM, Mochizuki N, Kim J, et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 2005; 97: 86-94.
13. Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, Lee SH, Yasunaga K, Kim KT, Kim I, Choi HH, et al. COMP-Ang1: a designed angiopoietin- 1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 2004; 101: 5547-52.
14. Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension 1997; 29: 728-35.
15. Park SH, Kim M, Min K, Park K. Erectile function and cavernosal TGFbeta expression in the OLETF rats. Korean J Androl 2002; 20: 82-6.
16. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999; 103: 1231-6.
17. Freedman SB, Isner JM. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 2001; 33: 379-93.
18. Ryu JK, Shin HY, Song SU, Oh SM, Piao S, Han JY, Park KW, Suh JK. Downregulation of angiogenic factors and their downstream target molecules affects the deterioration of erectile function in a rat model of hypercholesterolemia. Urology 2006; 67: 1329-34.
19. Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167: 761-7.
20. Gholami SS, Rogers R, Chang J, Ho HC, Grazziottin T, Lin CS, Lue TF. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003; 169: 1577-81.
21. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
22. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998; 282: 468-71.
23. Baffert F, Thurston G, Rochon-Duck M, Le T, Brekken R, McDonald DM. Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res 2004; 94: 984-92.
24. Ryu JK, Cho CH, Shin HY, Song SU, Oh SM, Lee M, Piao S, Han JY, Kim IH, Koh GY, et al. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006; 13: 705- 15.
25. Cho CH, Sung HK, Kim KT, Cheon HG, Oh GT, Hong HJ, Yoo OJ, Koh GY. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci U S A 2006; 103: 4946-51.